RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Iovance Biotherapeutics Net Income 2024

Iovance Biotherapeutics Net Income

-366.8 M USD

Iovance Biotherapeutics Dividend yield

Ticker

IOVA

ISIN

US4622601007

WKN

A2DT49

In 2024, Iovance Biotherapeutics's profit amounted to -366.8 M USD, a -17.39% increase from the -444.04 M USD profit recorded in the previous year.

The Iovance Biotherapeutics Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-
2012-
2011-
2010-
2009-
2008-
2007-

Iovance Biotherapeutics Aktienanalyse

What does Iovance Biotherapeutics do?

Iovance Biotherapeutics Inc is a US biotechnology company specializing in the development of personalized immunotherapies for cancer patients. The company was founded in 2007 by Dr. Dendy Engelman and is headquartered in San Carlos, California. Iovance Biotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Iovance Biotherapeutics's Profit Margins

The profit margins of Iovance Biotherapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Iovance Biotherapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Iovance Biotherapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Iovance Biotherapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Iovance Biotherapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Iovance Biotherapeutics Stock

How much profit has Iovance Biotherapeutics made this year?

Iovance Biotherapeutics has made -366.8 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -17.39% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Iovance Biotherapeutics publish its earnings?

Iovance Biotherapeutics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Iovance Biotherapeutics?

The profits of Iovance Biotherapeutics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Iovance Biotherapeutics?

You can learn more about the earnings of Iovance Biotherapeutics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Iovance Biotherapeutics pay?

Over the past 12 months, Iovance Biotherapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Iovance Biotherapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Iovance Biotherapeutics?

The current dividend yield of Iovance Biotherapeutics is .

When does Iovance Biotherapeutics pay dividends?

Iovance Biotherapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Iovance Biotherapeutics?

Iovance Biotherapeutics paid dividends every year for the past 0 years.

What is the dividend of Iovance Biotherapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Iovance Biotherapeutics located?

Iovance Biotherapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Iovance Biotherapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Iovance Biotherapeutics from 4/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/30/2024.

When did Iovance Biotherapeutics pay the last dividend?

The last dividend was paid out on 4/30/2024.

What was the dividend of Iovance Biotherapeutics in the year 2023?

In the year 2023, Iovance Biotherapeutics distributed 0 USD as dividends.

In which currency does Iovance Biotherapeutics pay out the dividend?

The dividends of Iovance Biotherapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Iovance Biotherapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Iovance Biotherapeutics

Our stock analysis for Iovance Biotherapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Iovance Biotherapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.